Annual Immuno-Oncology Summit

The summit will feature a comprehensive program covering a wide range of topics, including:

• Bi- and Multispecific Engineering: Exploring nanobody applications, functional bispecifics, target selection, and engineering for solid tumors.
• Translating Multispecific Success: Combining multispecifics with cellular modalities, leveraging machine learning in development, addressing safety and regulatory hurdles, and insights from solid tumor clinical successes.
• Antibody-Drug Conjugates (ADCs): Advancements in linker technologies, site-specific conjugation, overcoming resistance and toxicity, and enhancing targeting specificity.
• Breakthroughs in Cell Therapy: Developments in CAR T therapy, TILs, TCRs, Tregs for solid tumors, combining multiple cell therapies, and reducing clinical attrition rates.
• Autoimmunity: Applying immuno-oncology learnings to autoimmunity, B cell targeting, understanding the autoimmune microenvironment, and transient therapeutic approaches.
• Innate Immunity: Insights into solid tumor biology, advancements in NK cell engagers and gamma delta developments, applications of machine learning and data science, and translatable models.